{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041706","form_type":"8-K","ticker":"AZTR","cik":"0001701478","company_name":"Azitra, Inc.","filed_at":"2026-09-08T12:05:29+00:00","discovered_at":"2026-09-08T12:10:00.469879+00:00","generated_at":"2026-09-08T12:10:18.749288+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Azitra to present at H.C. Wainwright conference; update on ATR-COSF and ATR-04","bullets":["COO Travis Whitfill to present virtually at H.C. Wainwright 28th Annual Global Investment Conference, Sept 14-16, 2026.","Presentation will include initial data from ATR-COSF program for cosmetic applications targeting fine lines and wrinkles.","Will discuss continued enrollment in first cohort of Phase 1/2 trial of ATR-04 for EGFR inhibitor-associated rash.","ATR-04 has FDA Fast Track designation; EGFRi rash impacts ~150,000 people in U.S."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041706","json":"https://secwatch.observer/filing/0001493152-26-041706.json","markdown":"https://secwatch.observer/filing/0001493152-26-041706.md","text":"https://secwatch.observer/filing/0001493152-26-041706.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1701478/000149315226041706/0001493152-26-041706-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1701478/000149315226041706/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-08T12:10:18.749288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}